MAIA Biotechnology
Mr. Chiam is a Partner at EY’s M&A Strategy & Operations practice. He has over 20 years of management consulting experience advising clients on complex mergers, acquisitions, divestitures, spin-offs and restructurings. Some examples of his sector experience include: (1) helping a private equity client buy and stand-up a global medical device business from a Fortune 50 company, (2) advising on an IPO and spin-off of an animal health business from a Fortune 50 pharma company, and (3) supporting a generics pharma in the acquisition and integration of another business.
Mr. Chiam holds an M.B.A. from the University of Virginia Darden School of Business.
This person is not in the org chart
This person is not in any teams
MAIA Biotechnology
2 followers
MAIA Biotechnology is a targeted therapy, immune-oncology company, focused on development and commercialization of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer.